(Q37381690)

20 August 2017

1 reference

title

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice (English)

1 reference

20 August 2017

M Battiwalla

1

1 reference

20 August 2017

P L McCarthy

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

2 February 2009

1 reference

Bone Marrow Transplantation

20 August 2017

published in

1 reference

20 August 2017

volume

43

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

351-356

1 reference

Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Granulocytic colony-stimulating factors in the management of patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Induction of T-cell mitogenic unresponsiveness by recombinant human granulocyte colony-stimulating factor (rHuG-CSF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: report of two cases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Granulocyte colony-stimulating factor (G-CSF) dependent hematopoiesis with monosomy 7 in a patient with severe aplastic anemia after ATG/CsA/G-CSF combined therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

The evidence of clonal evolution with monosomy 7 in aplastic anemia following granulocyte colony-stimulating factor using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Long-term administration of G-CSF for aplastic anaemia is closely related to the early evolution of monosomy 7 MDS in adults

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Collection of peripheral blood stem cells from normal donors 60 years of age or older

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for B

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Guidelines of the National Comprehensive Cancer Network on the use of myeloid growth factors with cancer chemotherapy: a review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: a report on 283 cases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2008.443

7 January 2021

Identifiers

DOI

10.1038/BMT.2008.443

1 reference

20 August 2017

1 reference